Literature DB >> 34705480

β-Arrestins as Important Regulators of Glucose and Energy Homeostasis.

Sai P Pydi1,2, Luiz F Barella1, Lu Zhu1, Jaroslawna Meister1, Mario Rossi1,3, Jürgen Wess1.   

Abstract

β-Arrestin-1 and -2 (also known as arrestin-2 and -3, respectively) are ubiquitously expressed cytoplasmic proteins that dampen signaling through G protein-coupled receptors. However, β-arrestins can also act as signaling molecules in their own right. To investigate the potential metabolic roles of the two β-arrestins in modulating glucose and energy homeostasis, recent studies analyzed mutant mice that lacked or overexpressed β-arrestin-1 and/or -2 in distinct, metabolically important cell types. Metabolic analysis of these mutant mice clearly demonstrated that both β-arrestins play key roles in regulating the function of most of these cell types, resulting in striking changes in whole-body glucose and/or energy homeostasis. These studies also revealed that β-arrestin-1 and -2, though structurally closely related, clearly differ in their metabolic roles under physiological and pathophysiological conditions. These new findings should guide the development of novel drugs for the treatment of various metabolic disorders, including type 2 diabetes and obesity.

Entities:  

Keywords:  G protein–coupled receptors; genetically modified mice; insulin resistance; obesity; type 2 diabetes; β-arrestins

Mesh:

Substances:

Year:  2021        PMID: 34705480     DOI: 10.1146/annurev-physiol-060721-092948

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  3 in total

1.  Dual roles of β-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer.

Authors:  Huan Yu; Man Wang; Ting Zhang; Lihua Cao; Zhongwu Li; Yang Du; Yanru Hai; Xiangyu Gao; Jiafu Ji; Jianmin Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

Review 2.  The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models.

Authors:  Jürgen Wess
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

3.  Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.

Authors:  Despoina Aslanoglou; Suzanne Bertera; Laura Friggeri; Marta Sánchez-Soto; Jeongkyung Lee; Xiangning Xue; Ryan W Logan; J Robert Lane; Vijay K Yechoor; Peter J McCormick; Jens Meiler; R Benjamin Free; David R Sibley; Rita Bottino; Zachary Freyberg
Journal:  iScience       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.